Biomea Fusion Stock Quote BMEA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

10.78

Bid

10.51

Ask

10.99

Volume

0.00 Day's Range 0.00

8.125 52 Week Range 43.69

Market Cap

384.908M

Previous Close

10.78

Open

Last Trade

10.9

Last Trade Time

08:00:02

Financial Volume

VWAP

Average Volume (3m)

1,047,922

Shares Outstanding

35,705,786

Dividend Yield

PE Ratio

-3.28

Earnings Per Share (EPS)

-3.28

Revenue

Net Profit

-117.26M

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.biomeafusion.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Biomea Fusion Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BMEA. The last closing price for Biomea Fusion was $10.78. Over the last year, Biomea Fusion shares have traded in a share price range of $ 8.125 to $ 43.69.

Biomea Fusion currently has 35,705,786 shares outstanding. The market capitalization of Biomea Fusion is $384.91 million. Biomea Fusion has a price to earnings ratio (PE ratio) of -3.28.

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and...

Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes The first two type 1 diabetes patients enrolled in...

Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

In 2023, reported Phase 2 data (COVALENT-111) in type 2 diabetes patients supporting the disease-modifying potential of BMF-219 to address a root cause of diabetes: a loss of healthy...

Form 8-K - Current report

Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle, Supporting Improved Pancreatic Function

Three Clinical Data Sets from the Dose Escalation Phase of COVALENT-111 to be Presented at the 17th Annual ATTD Conference Highlighting BMF-219’s Novel Mechanism of Action in Patients with Type 2...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.23	-2.08900999092	11.01	11.39	10.26	645697	10.78099058	CS
4	-4.57	-29.7719869707	15.35	16.29	10.22	1026667	12.39288308	CS
12	-7.48	-40.9638554217	18.26	19.89	10.22	1047922	15.31877511	CS
26	-0.16	-1.46252285192	10.94	22.74	8.125	1177776	14.93449292	CS
52	-18.85	-63.6179547756	29.63	43.69	8.125	906122	18.33014912	CS
156	-6.74	-38.4703196347	17.52	43.69	2.84	446338	18.41134949	CS
260	-9.22	-46.1	20	43.69	2.84	446342	18.40722569	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCPHDeciphera Pharmaceuticals Inc	$ 25.05 (70.99%)	5.02M
INHDInno Holdings Inc	$ 0.932 (47.82%)	10.58M
CSPICSP Inc	$ 18.46 (36.44%)	13
ZVSAZyVersa Therapeutics Inc	$ 6.78 (35.87%)	784.85k
SRZNSurrozen Inc	$ 12.00 (33.63%)	11
CLVRClever Leaves Holdings Inc	$ 1.59 (-61.31%)	117.85k
MRXMarex Group PLC	$ 7.60 (-60.00%)	1.04k
ADXNAddex Therapeutics Ltd	$ 7.43 (-53.85%)	19.01k
TSDDGraniteShares ETF Trust GraniteShares	$ 19.20 (-22.89%)	130.56k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 30.50 (-22.33%)	718.87k
AKANAkanda Corporation	$ 0.124 (20.39%)	20.9M
ARQQArqit Quantum Inc	$ 0.5998 (22.99%)	13.16M
PEGYPineapple Energy Inc	$ 0.0688 (9.90%)	10.96M
INHDInno Holdings Inc	$ 0.932 (47.82%)	10.58M
SOFISoFi Technologies Inc	$ 8.10 (2.92%)	9.75M